Wei W - Search Results

1

Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy.

Fan Y, Gao Y, Nie L, Hou T, Dan W, Wang Z, Liu T, Wei Y, Wang Y, Liu B, Que T, Lei Y, Zeng J, Ma J, Wei W, Li L. Fan Y, et al. Among authors: wei y, wei w. Mol Cell. 2023 Oct 5;83(19):3520-3532.e7. doi: 10.1016/j.molcel.2023.09.007. Mol Cell. 2023. PMID: 37802025 Free article.

2

Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.

Min SH, Lau AW, Lee TH, Inuzuka H, Wei S, Huang P, Shaik S, Lee DY, Finn G, Balastik M, Chen CH, Luo M, Tron AE, Decaprio JA, Zhou XZ, Wei W, Lu KP. Min SH, et al. Among authors: wei s, wei w. Mol Cell. 2012 Jun 29;46(6):771-83. doi: 10.1016/j.molcel.2012.04.012. Epub 2012 May 17. Mol Cell. 2012. PMID: 22608923 Free PMC article.

3

Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Zhang J, Dang F, Ren J, Wei W. Zhang J, et al. Among authors: wei w. Trends Biochem Sci. 2018 Dec;43(12):1014-1032. doi: 10.1016/j.tibs.2018.09.004. Epub 2018 Oct 1. Trends Biochem Sci. 2018. PMID: 30287140 Free PMC article. Review.

4

PROTACs: A novel strategy for cancer therapy.

Liu J, Ma J, Liu Y, Xia J, Li Y, Wang ZP, Wei W. Liu J, et al. Among authors: wei w. Semin Cancer Biol. 2020 Dec;67(Pt 2):171-179. doi: 10.1016/j.semcancer.2020.02.006. Epub 2020 Feb 11. Semin Cancer Biol. 2020. PMID: 32058059 Review.

5

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy.

Gao Y, Nihira NT, Bu X, Chu C, Zhang J, Kolodziejczyk A, Fan Y, Chan NT, Ma L, Liu J, Wang D, Dai X, Liu H, Ono M, Nakanishi A, Inuzuka H, North BJ, Huang YH, Sharma S, Geng Y, Xu W, Liu XS, Li L, Miki Y, Sicinski P, Freeman GJ, Wei W. Gao Y, et al. Among authors: wei w. Nat Cell Biol. 2020 Sep;22(9):1064-1075. doi: 10.1038/s41556-020-0562-4. Epub 2020 Aug 24. Nat Cell Biol. 2020. PMID: 32839551 Free PMC article.

6

Ubiquitin signaling in cell cycle control and tumorigenesis.

Dang F, Nie L, Wei W. Dang F, et al. Among authors: wei w. Cell Death Differ. 2021 Feb;28(2):427-438. doi: 10.1038/s41418-020-00648-0. Epub 2020 Oct 31. Cell Death Differ. 2021. PMID: 33130827 Free PMC article. Review.

7

Post-translational regulations of PD-L1 and PD-1: Mechanisms and opportunities for combined immunotherapy.

Dai X, Gao Y, Wei W. Dai X, et al. Among authors: wei w. Semin Cancer Biol. 2022 Oct;85:246-252. doi: 10.1016/j.semcancer.2021.04.002. Epub 2021 Apr 5. Semin Cancer Biol. 2022. PMID: 33831533 Free PMC article. Review.

8

Extracellular and nuclear PD-L1 in modulating cancer immunotherapy.

Xiong W, Gao Y, Wei W, Zhang J. Xiong W, et al. Among authors: wei w. Trends Cancer. 2021 Sep;7(9):837-846. doi: 10.1016/j.trecan.2021.03.003. Epub 2021 Apr 23. Trends Cancer. 2021. PMID: 33903073 Review.

9

Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade.

Dai X, Bu X, Gao Y, Guo J, Hu J, Jiang C, Zhang Z, Xu K, Duan J, He S, Zhang J, Wan L, Liu T, Zhou X, Hung MC, Freeman GJ, Wei W. Dai X, et al. Among authors: wei w. Mol Cell. 2021 Jun 3;81(11):2317-2331.e6. doi: 10.1016/j.molcel.2021.03.037. Epub 2021 Apr 27. Mol Cell. 2021. PMID: 33909988 Free PMC article.

10

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.

Dang F, Nie L, Zhou J, Shimizu K, Chu C, Wu Z, Fassl A, Ke S, Wang Y, Zhang J, Zhang T, Tu Z, Inuzuka H, Sicinski P, Bass AJ, Wei W. Dang F, et al. Among authors: wei w. Nat Commun. 2021 Sep 10;12(1):5386. doi: 10.1038/s41467-021-25700-6. Nat Commun. 2021. PMID: 34508104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,590 results

Search Page